153 related articles for article (PubMed ID: 16933718)
1. Angiogenesis in myelodysplastic syndromes (MDS) in Indian patients.
Dutta P; Bhattacharya J; Karak AK; Gupta M; Chatterjee T; Srinivas U; Mishra P; Saxena R
Indian J Pathol Microbiol; 2006 Apr; 49(2):218-20. PubMed ID: 16933718
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis in myelodysplastic syndromes.
Pruneri G; Bertolini F; Soligo D; Carboni N; Cortelezzi A; Ferrucci PF; Buffa R; Lambertenghi-Deliliers G; Pezzella F
Br J Cancer; 1999 Dec; 81(8):1398-401. PubMed ID: 10604739
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
4. Clinical, hematological and histomorphological profile of myelodysplastic syndrome.
Nigam S; Rani S; Singh T; Gupta S; Rakheja D; Gaiha M
J Assoc Physicians India; 2001 Apr; 49():430-4. PubMed ID: 11762613
[TBL] [Abstract][Full Text] [Related]
5. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
Zou WR; Liu T; Meng WT; Yu J; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
7. Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.
Alexandrakis MG; Passam FH; Pappa CA; Sfiridaki K; Tsirakis G; Damilakis J; Stathopoulos EN; Kyriakou DS
Leuk Res; 2005 Jan; 29(1):41-6. PubMed ID: 15541473
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of WHO classification and MDS 2000 classification in myelodysplastic syndromes].
Akiba M; Matsuda A; Misumi M; Yagasaki F; Bessho M
Rinsho Ketsueki; 2001 Dec; 42(12):1162-9. PubMed ID: 11828718
[TBL] [Abstract][Full Text] [Related]
9. Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia.
Patsouris E; Korkolopoulou P; Androulaki A; Douzinas E; Kosmopoulou O; Kordossis T
Pathology; 2003 Aug; 35(4):330-5. PubMed ID: 12959769
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia.
Kyriakou D; Eliopoulos AG; Alexandrakis M; Kalokyri I; Eliopoulos GD
Haematologia (Budap); 1996; 28(1):1-7. PubMed ID: 9283897
[TBL] [Abstract][Full Text] [Related]
11. [Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation].
Tomonaga M; Jinnai I; Kuriyama K; Nonaka H; Amenomori T; Matsuo T; Yoshida Y; Sasagawa I; Sadamori N; Ichimaru M
Rinsho Ketsueki; 1989 Oct; 30(10):1788-99. PubMed ID: 2593245
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
13. [Myelosclerosis in myelodysplastic syndromes (MDS). Retrospective analysis of 232 patients with MDS].
Maschek H; Kaloutsi V; Werner M; Bandecar K; Buhr T; Georgii A
Verh Dtsch Ges Pathol; 1990; 74():144-8. PubMed ID: 1708573
[TBL] [Abstract][Full Text] [Related]
14. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R
Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
[TBL] [Abstract][Full Text] [Related]
15. A study of the haematologic spectrum of myelodysplastic syndrome.
Kini J; Khadilkar UN; Dayal JP
Indian J Pathol Microbiol; 2001 Jan; 44(1):9-12. PubMed ID: 12561987
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
Hamdi W; Ogawara H; Handa H; Tsukamoto N; Nojima Y; Murakami H
Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862
[TBL] [Abstract][Full Text] [Related]
17. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
18. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
Keith T; Araki Y; Ohyagi M; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Kitagawa M
Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
[TBL] [Abstract][Full Text] [Related]
19. [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP].
Li X; Pu Q; Liu Y; Shi J; Tao Y; Chang C; Jiang Q; Huang W
Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):27-9. PubMed ID: 12015085
[TBL] [Abstract][Full Text] [Related]
20. Expression of the proliferation-associated nuclear protein MIB-1 and its relationship with microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes.
Alexandrakis MG; Passam FH; Kyriakou DS; Dambaki C; Katrinakis G; Tsirakis G; Konsolas J; Stathopoulos EN
J Mol Histol; 2004 Nov; 35(8-9):857-63. PubMed ID: 15609099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
